Press releases
08-22-2011
curasan AG receives European license for bone regeneration material with optimised handling features
Kleinostheim, 22.08.2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received the European approval for Cerasorb® foam for two different product versions...
07-25-2011
curasan AG signs exclusive sales agreement with Zimmer Dental Inc., USA
Kleinostheim, July 25, 2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights for Osbone®, Ceracell® and Osseolive® synthetic bone grafting products for regenerative dental applications....
05-05-2011
curasan AG receives license for Ceracell® Dental in the USA
Kleinostheim, Germany, 5th May 2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8) has received FDA certification for its new granular bone regeneration material Ceracell® Dental...
03-28-2011
curasan AG: Novel bone regeneration material approved for sale in Europe
Kleinostheim, Germany, 28th March 2011 – curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received European approval for a novel synthetic bone regeneration material...
02-10-2011
curasan AG receives license for Osbone® Dental in the USA
Kleinostheim, Germany, 10th February 2011 - curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received FDA certification and, therefore, marketing authorization throughout the USA of the synthetic bone replacement material Osbone® Dental which already has been authorized in the EU as Osbone®...
02-09-2011
curasan AG signs sales agreement with Stryker S.A.
Kleinostheim, Germany, 9 February 2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different orthopedic indications...
01-11-2011
curasan Inc. and TransCorp Spine Inc. sign supply agreement for the US-market
Kleinostheim, Germany, 11th January 2011 – curasan Inc., the north American subsidiary of exchange listed curasan AG, Germany, (ISIN: DE 000 549 453 8), has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms ...